Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

MarketBeat · May 13

What to know about Kyle Diamantas, the new acting FDA commissioner

The ex-lawyer who Trump described as ‘very talented’ was previously deputy commissioner for food at the FDA

The Guardian - US · May 13

Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer

Abbott’s business and dividend story remain intact even as the stock trades near 52‑week lows.

Barchart · May 5

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA finds US infant formula supply is ‘safe’ after examining 300 samples in Operation Stork Speed

The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project

The Independent UK · Apr 29

US infant formula supply is 'safe,' FDA says after looking for potential contaminants

Federal health officials said a new analysis of U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants

The Independent UK · Apr 29

This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio

Abbott Labs is a balance of income and growth.

Barchart · Apr 23

Abbott Stock Crash: Rebound Could Be Coming Fast

Abbott Laboratories' stock price sell-off is overextended in mid-April, creating an opportunity that income investors will not want to miss.

MarketBeat · Apr 17

Read news from The Economist, FT, and more,
with one subscription

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors.

MarketBeat · Apr 7

Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?

Johnson & Johnson offers scale and stability, but Abbott’s cheaper valuation, higher yield, and stronger upside make it the more attractive pick now.

Barchart · Apr 3

Buy the Dip: These 3 Over-$100 Stocks Just Hit New 52-Week Lows

Among the 128 new 52-week lows on the NYSE on Tuesday, there were five with share prices of $100 or higher. Not all of them are worth buying on the dip. We rate three that could be.

Barchart · Apr 1

This Dividend King Is Down 26%. When Will It Bounce Back?

Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound?

Barchart · Mar 31

Abbott Earnings Preview: What to Expect

Abbott is expected to announce its first-quarter results soon, and analysts are projecting single-digit EPS growth.

Barchart · Mar 25

3 High Dividend Growth Kings for Generations of Income That Are Still Rated ‘Buy’

These 3 Dividend Kings combine steady businesses, rising dividends, and solid upside potential for long-term income investors.

Barchart · Mar 18

This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip?

This Dividend King is suddenly on sale. Should you buy the dip?

Barchart · Mar 16

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Mar 11

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths

Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce falsely low glucose readings

Budget and the Bees · Feb 9

What to Know About Recent FDA Alerts Involving Glucose Monitors in 2026

For millions living with diabetes, a continuous glucose monitor (CGM) is more than technology. It is a lifeline that provides safety in an unpredictable world. These devices allow you to sleep without fear and eat without complex math. However, high-level FDA alerts can vanish that sense of security instantly. False…

The Independent UK · Feb 5

Coworkers of different generations mentor each other to reduce workplace misunderstandings

With at least five generations participating in the U.S. workforce, coworkers can at times feel like they speak different languages

The Independent UK · Feb 5

New implant for heart failure patients to be rolled out across the NHS

The British Heart Foundation estimates that more than a million people in the UK are living with heart failure

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Feb 4

Do Wall Street Analysts Like Abbott Laboratories Stock?

While Abbott Laboratories has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart · Jan 29

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

MarketBeat · Jan 24

Is Abbott’s January Pullback a Good Time to Buy?

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow.

Cinemablend · Jan 22

How Authentic Was Abbott Elementary In Relocating The Cast To An Abandoned Mall? Janelle James Opened Up About ‘Lots Of Smells’

At least the animatronic Ben Franklin head is dead!

MarketBeat · Jan 20

2 Healthcare Names That Could Get a Big Boost From Earnings

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

Fortune · Jan 17

Fortune 500 exec: College grads aren't ready for today's jobs

There's a missing link between college and career.

Cinemablend · Jan 4

With Abbott Elementary Nominated For Major Awards, The Stars Opened Up About Representing Traditional Sitcoms Against Streaming Competition

Will Abbott Elementary score in the awards circuit this year?

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.